Targeting neurons in the gastrointestinal tract to treat Parkinson's disease
Clinical Parkinsonism & Related Disorders(2019)
摘要
Orally administered ENT-01 was safe and significantly improved bowel function in PD, suggesting that the ENS is not irreversibly damaged in PD. Minimal systemic absorption suggests that improvements result from local stimulation of the ENS. A double-blind, placebo-controlled study is now ongoing.
更多查看译文
关键词
Squalamine,ENT-01,Parkinson's disease,Constipation,Treatment,Non-motor,Synuclein
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要